2ⁿᵈ Edition of the Cancer R&D World Conference 2026

Scientific Sessions

Breast Cancer

Breast cancer is a malignant tumour that originates in the breast tissue, often arising in the ducts or lobules. It is the most prevalent cancer among women globally. Critical challenges in addressing breast cancer include late-stage diagnoses due to insufficient screening, disparities in access to healthcare, and varied responses to treatments, which can lead to resistance. To overcome these issues, it is essential to enhance public awareness about the importance of early detection, improve access to screening programs, and invest in research focused on personalized therapies that cater to the individual genetic profiles of patients

Related Sessions

Current Landscape and Future Directions of Oncology Research
Oncogenic Signaling Pathways and Therapeutic Targets
Emerging Biomarkers for Cancer Detection and Prognosis
Cancer Prevention and Early Detection Strategies
Immuno-Oncology and Cell-Based Therapies
Innovations in Immuno-Oncology
Cytokine Modulation and Immune Adjuvants in Cancer Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy: Clinical Progress and Challenges
Next-Generation Cell and Gene Therapies in Oncology
Liquid Biopsy and Circulating Tumor DNA (ctDNA) Diagnostics
Companion Diagnostics
Artificial Intelligence and Machine Learning in Precision Oncology
Next-Generation Targeted Therapies: KRAS, HER2, BRAF, and NRAS
Overcoming Drug Resistance: Mechanisms and Solutions
Oncology Pipeline
Trends in Antibody–Drug Conjugates (ADCs)
Launch of Novel mAb Products for Cancer Therapy